Founded with a mission to revolutionize neurological recovery, SpineX develops cutting-edge neuromodulatory tools and rehabilitation devices. Their core vision is to restore vital functions for patients with unmet medical needs, including those suffering from strokes, spinal cord injuries, multiple sclerosis, traumatic brain injuries, and cerebral palsy. SpineX's flagship products, SCiP™ and SCONE™, are non-invasive spinal cord neuromodulation devices designed to treat neurogenic bladder and other neurological conditions, aiming to improve bladder, bowel, respiration, sexual, and sensorimotor functions.

SpineX has garnered attention through its innovative approach and rigorous testing of neuromodulation technologies. The company is supported by notable investors and has formed affiliations with leading research institutions. Key achievements include successful clinical trials and significant advancements in non-invasive treatment methodologies. SpineX's impact is profound, offering new hope and improved quality of life for individuals with severe neurological impairments.